University of Minnesota / Masonic Cancer Center — Minneapolis, Minnesota

University of Minnesota / Masonic Cancer Center is a clinical research site located in Minneapolis, Minnesota, United States 55455.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

University of Minnesota / Masonic Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Neurofibromatosis Type 2, Relapsed Solid Tumor, Refractory Solid Tumor.

Sponsors: Recursion Pharmaceuticals Inc., Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Minnesota / Masonic Cancer Center?

University of Minnesota / Masonic Cancer Center has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Minnesota / Masonic Cancer Center conducted?

University of Minnesota / Masonic Cancer Center has 2 clinical trials on record. Their work covers Neurofibromatosis Type 2, Relapsed Solid Tumor, Refractory Solid Tumor.

Is University of Minnesota / Masonic Cancer Center accredited by Crixeo Health?

University of Minnesota / Masonic Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Minnesota / Masonic Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.